课题基金 / 基金详情

The new approach to the diabetogenic mechanism and the new therapy : The disturbance of insulin secretion by oxidized lipoproteins and its relief

The new approach to the diabetogenic mechanism and the new therapy : The disturbance of insulin secretion by oxidized lipoproteins and its relief
糖尿病发生机制的新途径和新疗法:氧化脂蛋白对胰岛素分泌的干扰及其缓解
批准号:
15590959
负责人:
OIKAWA Shinichi
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

OIKAWA Shinichi的其他基金

相似基金

相关文献

中文摘要
翻译
我们研究了低密度脂蛋白(LDL)是否影响胰岛β细胞的胰岛素分泌。我们推测修饰后的低密度脂蛋白通过脂蛋白受体摄取低密度脂蛋白后对胰岛β细胞功能有影响,因此我们首先检查了胰岛β细胞中是否存在脂蛋白受体。用抗大鼠胰岛素抗体、抗低密度脂蛋白受体(LDL-R)抗体和抗清道夫受体抗体(CD36和SRB1)对胰岛β细胞进行免疫染色。抗胰岛素抗体阳性细胞同时进行抗低密度脂蛋白受体抗体、抗CD36抗体和抗SRB1抗体染色。这些结果表明,β细胞不仅有普遍表达的低密度脂蛋白受体,还伴随有清道夫受体。为了研究各受体在β细胞中的表达情况,我们制备了大鼠肝、肾、胰岛和Hit-T15细胞的总rna,这些细胞系来源于Hamst…。更多的呃胰岛β细胞。大鼠肝脏分别表达低密度脂蛋白受体、SRB1和CD36的mRNA。大鼠肾脏既有低密度脂蛋白受体又有SRB1受体的mRNA,但没有CD36的mRNA,这在任何地方都已经报道过。在大鼠胰岛和HIT-T15细胞中,低密度脂蛋白受体、SRB1和CD36的mRNA表达水平与肝脏相同。因此,推测脂蛋白可能通过受体被摄取,并影响胰岛素的分泌。为了检测HIT-T15细胞对脂蛋白的摄取,用DiI标记的天然低密度脂蛋白(NLDL)、氧化型低密度脂蛋白(OxLDL)和乙酰化低密度脂蛋白(AcLDL)培养HIT-T15细胞。荧光显微镜下可见HIT-T15细胞清晰可见,提示每种低密度脂蛋白均已内化到细胞内。这些结果表明,每种低密度脂蛋白都是通过每种受体摄取的。接下来,我们检测了用每种低密度脂蛋白培养的HIT-T15细胞的胰岛素分泌情况。将氧化型低密度脂蛋白(25或50μg/ml)加入HIT-T15细胞培养24或48小时。葡萄糖浓度分别为1、3、5 mg/ml时,oxLDL对胰岛素分泌和细胞内胰岛素含量的影响呈剂量和时间依赖性。加入oxLDL后,胰岛素基因的表达显著降低。在nLDL和添加AcLDL的培养中未发现这些结果。HIT-T15细胞胰岛素代谢的这些改变是由oxLDL引起的,而不是AcLDL引起的。结论oxLDL作用于胰岛β细胞,干扰胰岛素基因表达,降低细胞内胰岛素含量和胰岛素分泌。这些已发表在《生物化学生物物理学A-摩尔细胞生物学L》(1687:173-180,2005)上。较少
英文摘要
We have studied whether low-density lipoprotein(LDL) affected on the insulin secretion of pancreatic beta cells. We speculated that the modified LDLs affected on beta cell function after the uptake of LDL through lipoprotein receptor, so at first we checked that the lipoprotein receptors were found in the pancreatic beta cells. The immunostaining of the beta cells was performed with anti-rat insulin antibody, anti-LDL receptor(LDL-R) antibody, and anti-scavenger receptor antibodies (CD36 and SRB1). The positively stained cells with anti-insulin antibody were also stained with anti-LDL-R antibody, anti-CD36 antibody and anti-SRB1 antibody. These results indicated that the beta cells had not only LDL receptor, which was ubiquitously expressed, but also scavenger receptors concomitantly. In order to study how mRNA of each receptor was expressed in beta cells, we prepared the total RNA from rat liver, kidney, islets of pancreas and Hit-T15 cells, which were the cell line derived from hamst … More er pancreatic beta cells. The rat liver expressed each mRNA of LDL-R, SRB1, and CD36. The rat kidney had both receptors mRNA of LDL-R and SRB1, but not CD36 mRNA, which had already been reported in anywhere. In the rat islets and Hit-T15 cells each mRNA of LDL-R, SRB1 and CD36 was expressed as same as liver. Therefore it was suggested that lipoproteins would be up taken through the receptors and affect on insulin secretion. In order to check the lipoprotein uptake, Hit-T15 cells were cultured with DiI-labeled native LDL (nLDL), oxidized LDL (oxLDL), and acetylated LDL (AcLDL). Hit-T15 cells were clearly marked under the fluorescence microscopy, which suggested that every LDLs were internalized into the cells. These results suggested that each LDL was uptaken through each receptor. Next we checked the insulin secretion in Hit-T15 cells cultured with each LDL. OxLDL (25 or 50 μg/ml) were added into the culture of Hit-T15 cells for 24 or 48 hours. The glucose concentrations of the medium were set at 1,3,and 5mg/ml. The insulin secretion and the intracellular insulin contents in the culture with oxLDL were disturbed in the dose and time dependent manner. The expression of insulin gene was significantly decreased in the oxLDL addition. These results were not found in nLDL and AcLDL added culture. These changes of the insulin metabolism in Hit-T15 cells were caused by oxLDL and not by AcLDL. As conclusions oxLDL affected on the beta cells disturbing insulin gene espression and decreasing the intracellular insulin contents and the insulin seceretion. These have been published in Biochim Biophys A - Mol Cell Biol L(1687:173-180,2005). Less
期刊论文(49)
专著(0)
科研奖励(0)
会议论文
Isohumulones, bitter acids derived from hops, activate both peroxisome prolife rator-activated receptor aand g and reduce insulin resistance
异葎草酮(源自啤酒花的苦酸)可激活过氧化物酶体增殖物激活受体 a 和 g,并降低胰岛素抵抗
DOI: --
发表时间: 2004
期刊: F Biol Chem 279・32
影响因子: --
作者: [Yajima H, Ikeshima E, Shiraki M, Kanaya T, Fujiwara D, Odai H, Tsuboyama-Kasaoka N, Ezaki A, Oikawa S, Kondo K]
通讯作者: Kondo K
Obana N, Takagi S, Kinouchi Y, Tokita Y, Sekikawa A, Takahashi S, Hiwatashi N, Oikawa S, Shimosegawa T: "Telomere shortening of peripheral blood mononuclear cells in coronary disease patients with metabolic disorders"Int Med. 42・2. 150-153 (2003)
Obana N、Takagi S、Kinouchi Y、Tokita Y、Sekikawa A、Takahashi S、Hiwatashi N、Oikawa S、Shimosekawa T:“伴有代谢紊乱的冠心病患者外周血单核细胞的端粒缩短”Int Med 42・2。 150-153 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsuzawa Y, Kita T, Mabuchi H, Matsuzaki M, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H, The J-LIT Study Group: "Sustained reduction of serum choleseterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japa
Matsuzawa Y、Kita T、Mabuchi H、Matsuzaki M、Nakaya N、Oikawa S、Saito Y、Sasaki J、Shimamoto K、Itakura H、J-LIT 研究组:“低剂量 6 年持续降低血清胆固醇
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Oak J-H., Nakagawa K., Oikawa S, Miyazawa T: "Amadori-glycated phosphatidylethanolamine induces angiogenic differentiations in cultured human umbilical vein endothelial cells"FEBS Letters. 555・2. 419-423 (2003)
Oak J-H.、Nakakawa K.、Oikawa S、Miyazawa T:“Amadori 糖化磷脂酰乙醇胺诱导培养的人脐静脉内皮细胞的血管生成分化”FEBS Letters 555·2(2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 23 条
    Oxidative stress and phospholipid oxidation : mechanism for the facilitation of monocyte/macrophage adhesion
    • 批准号:
      21591165
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.66万
    • 财政年份:
      2009
    • 负责人:
      OIKAWA Shinichi
    • 依托单位:
    Biological response to oxidative stress as initial formation of atherosclerotic lesion and development of its treatment
    • 批准号:
      18591005
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.58万
    • 财政年份:
      2006
    • 负责人:
      OIKAWA Shinichi
    • 依托单位:
    Research of Novel Mechanism in the Genesis of Diabetes Mellitus: The Dysfunction of pancreatic beta cell by the Increase of Blood Lipid Peroxides
    • 批准号:
      13671202
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2001
    • 负责人:
      OIKAWA Shinichi
    • 依托单位:
    Analysis of apo E-gene abnormality in lipoprotein glomerulopathy
    • 批准号:
      07671101
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1995
    • 负责人:
      OIKAWA Shinichi
    • 依托单位:
    海外基金